Merck & Co (MRK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Apr, 2026Voting matters and shareholder proposals
Election of 13 directors is up for vote, with all nominees recommended by the board.
Advisory vote on executive compensation (say-on-pay) is included.
Ratification of the independent registered public accounting firm for 2026 is proposed.
Shareholder proposals include reports on DEI risks in federal contracting, healthcare coverage gaps, and political contributions; board recommends voting against these.
Board of directors and corporate governance
Board recommends all 13 director nominees for election at the annual meeting.
Executive compensation and say-on-pay
Non-binding advisory vote on the compensation of named executive officers is on the agenda.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Merck & Co
- 2025 saw robust growth, pipeline expansion, and strong governance, with a focus on sustainability.MRK
Proxy filing8 Apr 2026 - $6.7B deal adds TERN-701, a next-gen CML therapy, to drive hematology and oncology growth.MRK
M&A announcement8 Apr 2026 - Transforming to a diversified, innovation-driven portfolio with robust late-stage pipeline assets.MRK
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Oncology and animal health drove 7% sales growth, offsetting GARDASIL China declines.MRK
Q4 20243 Feb 2026 - Q4 sales up 5% to $16.4B; 2026 outlook includes Cidara charge and robust pipeline.MRK
Q4 20253 Feb 2026 - Q2 sales up 7% to $16.1B; oncology, pipeline, and guidance upgrades drive strong momentum.MRK
Q2 20242 Feb 2026 - Robust pipeline, strategic deals, and innovation drive growth outlook into the 2030s.MRK
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Strong pipeline momentum, Gardasil growth, and Winrevair launch drive long-term outlook.MRK
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - International growth, pipeline expansion, and diversification drive robust future outlook.MRK
Bank of America Global Healthcare Conference 202420 Jan 2026